Confo Therapeutics

Septerna, Inc

This biotechnology company develops small-molecule medicines targeting G protein-coupled receptors to treat patients with endocrine, inflammatory and metabolic diseases.

Interax

This company develops a computational pharmacology platform to design and optimise drug candidates targeting G-protein-coupled receptors for biopharmaceutical partners.

Caldan Therapeutics

The company develops small-molecule drugs targeting free fatty acid receptors to treat metabolic diseases, such as type 2 diabetes, for the pharmaceutical industry.

Congruence Therapeutics

This biotechnology company develops small molecule medicines for patients with metabolic, neurological, immunological and oncological diseases using machine learning and biophysics.

Antag Therapeutics

This company develops GIP receptor antagonist therapies to treat patients living with obesity, type 2 diabetes and metabolic disorders.

Skape.Bio

The company develops AI-designed biologic medicines targeting G protein-coupled receptors for the pharmaceutical industry.

Carmot Therapeutics

This biotechnology company develops drug therapies to treat metabolic diseases, such as obesity and diabetes, for patients with these conditions.

Tectonic Therapeutic

This biotechnology firm develops protein and antibody therapies targeting G-protein coupled receptors to treat patients with pulmonary hypertension and genetic bleeding disorders.